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Abstract The catalytic mechanism of an anti-idiotypic anti-
body, 9G4H9, displaying a L-lactamase activity was investi-
gated. Kinetics experiments suggest that some penicillinic
derivatives behave both as substrates and inactivators. Biochem-
ical and immunological experiments strongly indicate that
ampicillin may be regarded as a suicide substrate for hydrolysis
by 9G4H9. The anti-idiotypic network appears as a way to
create enzyme mimics with modified catalytic activities. ß 2001
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
Complementarity rules that govern antigen^antibody inter-
actions were extensively exploited to elicit antibodies with
desired properties. In 1974, N. Jerne has suggested that
anti-idiotypic antibodies possessing internal image properties
may regulate the immune response [1]. This property has led
to consider anti-idiotypic antibodies as surrogate antigens.
Therefore, many molecular functions were shown to be mim-
icked by anti-idiotypic antibodies. In particular, we have pre-
viously demonstrated that catalytic anti-idiotypic antibodies
can be obtained [2]. Recently, an anti-idiotypic monoclonal
IgG, 9G4H9, generated against an antibody recognizing the
active site of L-lactamase was obtained that displays a L-lac-
tamase-like activity [3]. L-Lactamases are key elements of bac-
terial resistance to antibiotics. They catalyze the hydrolysis of
molecules owing a L-lactam cycle by cleaving their endocyclic
amide bond. Class A L-lactamases function with an essential
serine residue. The role of some other amino acid residues is
still dealt with controversy, but the hydrolytic mechanism of
antibiotics by L-lactamases is well known (for review, see [4]).
The catalytic mechanism of 9G4H9 monoclonal antibody was
thus investigated to elucidate the extent of functional similar-
ities between the original enzyme and its mimicking counter-
part anti-idiotypic abzyme.
2. Materials and methods
2.1. Preparation of antibody
Ascitic £uids from mice injected with hybridoma cells were frac-
tionated by FPLC a⁄nity chromatography on HiTrap rProtein A
(Pharmacia Biotech). Binding and elution bu¡ers were ready made
and used according to commercial instructions (Bio-Rad). The solu-
tions were dialyzed overnight against phosphate-bu¡ered saline (PBS:
1.5 mM KH2PO4, 8.1 mM Na2HPO4, 2.7 mM KCl, 140 mM NaCl),
and centrifuged in MicrosepTM tubes (Pall Filtron ^ 30 kDa) at 8000
rpm for 35 min. The antibody concentration was evaluated by a
bicinchoninic acid test (BCA-Sigma) as detailed by the manufacturer’s
instructions.
2.2. Kinetic measurements
Hydrolysis of ampicillin (Sigma) by IgG 9G4H9 or by L-lactamase
A was spectrophotometrically followed at 232 nm in 100 mM phos-
phate bu¡er pH 7.4. For inhibition experiments, the product of hy-
drolysis was obtained after heat treatment of 10 mM penicillin G at
70‡C during 3 h. The composition of the resulting product was con-
trolled by electrospray ionization (ESI) mass spectroscopy (Finnigan
SSQ 710, San Jose, CA, USA).
2.3. Recognition of penicillin by 9G4H9
Binding of biotinylated penicillin to 9G4H9 was evaluated by en-
zyme-linked immunosorbent assay (ELISA). Each step was followed
by three washes in 0.05% Tween^PBS. Microtitration plates were
coated with 160 Wg/ml of avidin during 1 h at 37‡C in 50 mM carbo-
nate bu¡er pH 9.6. Antibodies were incubated during 1 h at 37‡C.
Dilutions of antibodies were performed in PBS. The revealation of
bound antibodies was carried out using peroxidase-conjugated goat
anti-mouse IgG, incubated 1 h at 37‡C, and followed by the addition
of 0.55 mM azino-bis(ethylbenzthiazoline sulfonate) (ABTS) in 25
mM citrate bu¡er pH 5.0 containing 0.01% H2O2. The resulting ab-
sorbance was measured at 405 nm.
2.4. Western blotting
A Bio-Rad Mini-Trans-Blot apparatus with microcomputer electro-
phoresis power supply (Bioblock E752) was used for these experi-
ments. The migration of samples in Laemmli bu¡er [5], in a 10%
polyacrylamide gel electrophoresis (PAGE) was carried out in two
steps: at 90 V in the stacking gel and at 150 V in the separating
gel. The transfer on nitrocellulose membrane was done at 100 V
and 250 mA for 1 h. For blocking, the membrane was twice incubated
in 5% Milk^tris-bu¡ered saline (TBS: 50 mM tris(hydroxymethyl)-
aminomethane, 150 mM NaCl) during 30 min. After three washes
in 0.05% Tween^TBS, the membrane was incubated with 1 Wg/ml
peroxidase-conjugated avidin during 1 h. Blots were revealed, after
three washes, by incubating with 0.55 mM ABTS.
3. Results
3.1. Hydrolysis of L-lactamase substrates by 9G4H9
Monoclonal anti-idiotypic IgG 9G4H9 was previously de-
scribed to e⁄ciently catalyze the hydrolysis of penicillin and
cephalosporin compounds [3]. Catalytic parameters measured
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for ampicillin hydrolysis kcat = 0.9 min31 and KM = 2 mM
clearly show a loss in e⁄ciency when compared with the val-
ues measured with L-lactamase from Bacillus cereus (EC
3.5.2.6), kcat = 2.8U105 min31 and KM = 0.2 mM. However
the catalytic e⁄ciency measured with 9G4H9 is one of the
highest when compared to elicited abzymes previously de-
scribed to catalyze amide bond hydrolysis [6,7]. On the other
hand, 9G4H9 clearly demonstrated to be a true anti-idiotypic
antibody since polyclonal anti-9G4H9 antibodies (Ab3) were
shown to recognize B. cereus L-lactamase [3].
Surprisingly, ampicillin and penicillin hydrolysis by 9G4H9
exhibits a decrease in activity during the course of the hydro-
lytic reaction, and is characterized by a multiple turnover pre-
steady state burst before reaching an apparent steady state.
This behavior could be explained either as a denaturation
process of the antibody during the reaction or as a progressive
inactivation of the catalytic activity by the substrate itself or
even by the product of the reaction. However, no loss in
activity was observed for 9G4H9 in the absence of catalytic
reaction. When 3.3 WM 9G4H9 were preincubated with 1 mM
ampicillin and then tested for catalytic activity, the burst ob-
served for initial velocity of hydrolysis decreased with incuba-
tion time (Fig. 1). Moreover, the addition of substrate during
the steady state does not induce a new burst in hydrolysis
velocity. On the other hand, when 9G4H9 was preincubated
with the product of hydrolysis of penicillin G, a very slight
decrease in velocity was observed that could not explain the
observed phenomenon. We have checked by mass spectrosco-
py analysis the purity of penicillinoic acid, the product of
hydrolysis obtained by heat treatment. Taken together, these
observations do not allow to explain the observed catalytic
behavior of 9G4H9 by the denaturation of the abzyme during
the reaction, neither by a reversible inhibition of the catalyst
by the product of hydrolysis of the substrate.
These results suggest that ampicillin and penicillin G could
act both as a substrate and as an inactivator of the abzyme
like other suicide substrates. The observed behavior could
thus be explained by a substrate-suicide mechanism involving
concurrently the hydrolysis of the substrate or its covalent
binding to the catalyst.
3.2. Characterization of an irreversible complex between
9G4H9 and a penicillin derivative
The hypothesis of a mechanism-based inactivation of
9G4H9 by some penicillinic substrates was tested by reacting
the abzyme with biotinylated penicillin. Increasing 9G4H9
concentrations were incubated with 90 WM biotinylated pen-
icillin for 1 h at 20‡C to allow irreversible inactivation to
occur. The reacting medium was then transferred into micro-
titration wells previously coated with avidin in order to in-
solubilize all the species linked to biotin. The presence of
insolubilized penicillin complexed to antibody was revealed
using peroxidase-labeled anti-IgG antibodies (Fig. 2). In our
experimental conditions, unspeci¢c binding of 9G4H9 to avi-
din was never observed. On the other hand, by adding 1 mM
non-biotinylated penicillin G for 15 min at 20‡C to insolubi-
lized 9G4H9, we never observed any release of the antibody.
Consequently, no competition between biotinylated and non-
biotinylated penicillin could be measured. This suggests that
the 9G4H9 reaction with biotinylated penicillin forms either
an irreversible or a tight binding complex.
To further characterize the irreversible complex formed by
the catalytic reaction, Western blot experiments were per-
formed. 9G4H9 was incubated with biotinylated penicillin
for 1h and then tested on SDS^PAGE under reducing and
non-reducing conditions. After transfer on nitrocellulose
membrane, labeling with avidin-peroxidase clearly indicates
that 9G4H9 forms an irreversible complex with biotinylated
penicillin (Fig. 3). Electrophoresis under reducing conditions
demonstrates that the residues involved in binding with pen-
icillin are located on the light chain of the antibody. Once
Fig. 1. Hydrolytic activity of 3.3 WM 9G4H9 pre-incubated with
1 mM ampicillin for di¡erent times (F). The control experiments
(E) correspond to antibody incubated in 100 mM phosphate bu¡er
pH 7.4. The value of the residual activity, measured in the presence
of 850 WM penicillin G, is the mean of four independent determina-
tions ( þ standard deviation).
Fig. 2. Binding of 9G4H9 complexed with biotinylated penicillin on
160 Wg/ml avidin. Various amounts of antibody incubated with 90
WM biotinylated penicillin were tested for their ability to bind avidin
without (b) or with (F) competition by 1 mM non-biotinylated pen-
icillin G. The values are the means of three independent determina-
tions.
Fig. 3. Electrophoretic migration of 2.3 WM 9G4H9 under reducing
(lanes 1^3) and non-reducing conditions (lanes 4^6). M = Molecular
Weight Marker, lane 1: antibody incubated 1 h in phosphate bu¡er,
100 mM pH 7.4; lane 2: antibody incubated for 1 h with 36 WM
biotinylated penicillin; lane 3: antibody incubated for 45 min with
36 WM biotinylated penicillin and for 15 min with 10 mM penicillin
G; lane 4: antibody incubated with 130 WM biotinylated penicillin
for 1 h; lane 5: antibody incubated for 45 min with 130 WM bio-
tinylated penicillin and for 15 min with 10 mM penicillin G; lane 6:
antibody incubated 1 h in phosphate bu¡er, 100 mM pH 7.4.
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again, by adding 10 mM penicillin G to the labeled antibody,
no release of the biotinylated marker was observed. These
results reinforce the suicide substrate mechanism proposed
for the hydrolysis of penicillin substrates by 9G4H9. The sub-
strate hydrolysis could either form the product of the reaction
or undergo an alternative mechanism that results in irrevers-
ible binding to the abzyme and thus inactivation.
3.3. Inactivation mechanism
The suicide substrate mechanism proposed for ampicillin
interaction with 9G4H9 can be described by Scheme 1:
where Ab and Abi are the abzyme and inactivated abzyme
respectively, S is the substrate and P the product of hydroly-
sis. Ab.S is the abzyme^substrate complex and Abx the acyl^
abzyme intermediate.
According to Waley [8,9] the progress curve for the relative
concentration of inactivated abzyme can be expressed as:
t  N ln13M  z3N 0 ln13z 1
where:
z  Abi=Ab0
N  K 0=kinact13M S0
N 0  1=kinact  K 0=kinact13MS0
with:




k2  k3  k4
 
kinact  k2 k4=k2  k3  k4
and
M  1 k3=k4 Ab0=S0
The time for 50% inactivation (t1=2) is obtained experimen-
tally and Eq. 1 can be rearranged as:






By plotting [S]0 t1=2 against [S]0 for a series of [S]0 concen-
trations with keeping the ratio [Ab]0/[S]0 constant, the values
of kinact and KP can be calculated from the slope and intercept
respectively [10]. We found that the catalytic constant for
inactivation kinact = 0.024 min31 while KP, the Michaelis con-
stant for inactivation, was 2.5 mM.
4. Discussion
Class A L-lactamases function with a mechanism similar to
that of other enzymes, the DD-peptidases [11^13] that play a
role in the synthesis of the bacterial wall by cross-linking
polysaccharide linear chains. DD-peptidases are inactivated
by L-lactam antibiotics and therefore represent the major tar-
get in antibiotherapies. Penicillin derivatives covalently bind
to DD-peptidases by forming an acyl^enzyme complex much
more stable than the complex formed by the natural substrate
of the enzyme [14]. DD-peptidases and L-lactamases are both
serine enzymes involving an acyl^enzyme intermediate with L-
lactam substrates. However, the penicilloyl^enzyme intermedi-
ate involved in L-lactam ring opening by L-lactamase rapidly
deacylates [15].
When compared with the catalytic properties measured with
class A L-lactamase, the catalytic e⁄ciency of 9G4H9 anti-
body for L-lactam substrates is largely reduced. However
some similarities in the catalytic machinery seem to appear
between both catalysts. A nucleophilic residue is thus sug-
gested to play a key role by forming a covalent intermediate
during the catalytic process.
Surprisingly, the initial velocity of ampicillin hydrolysis by
9G4H9 rapidly deviates from linearity at low and even at high
substrate concentrations (s 20UKM). A multiple-turnover
pre-steady-state burst was observed before the reaction
reached steady state. The addition of more ampicillin during
the steady state does not induce a new burst, indicating that
this phenomenon is not due to a decrease in substrate con-
centration. We have checked that this result could not be
explained by a denaturation of the catalyst during the time
course of the reaction, nor by an inhibition of hydrolysis by
the product formed during ampicillin hydrolysis. Such a be-
havior was previously observed for the hydrolysis of phenyl
acetate by a monoclonal catalytic antibody 20G9 elicited
against a transition state analog [16]. The authors have pro-
posed a suicide-substrate mechanism to explain their results.
This mechanism involves turnover and inactivation, both oc-
curring via a Michaelis complex.
To check the occurrence of such a mechanism in ampicillin
and penicillin G hydrolysis by 9G4H9, the formation of an
irreversible complex during the reaction was tested using bio-
tinylated penicillin. The addition of high concentrations of
unlabeled penicillin was never found to dissociate the formed
complex. Moreover this stable complex was found to involve
amino acid residues present on the light chain of the antibody.
On the other hand, we observed that L-lactam derivatives,
cephalexin and nafcillin behave as reversible inhibitors of L-
lactamase TEM-1 from Escherichia coli, with Ki = 400 WM for
cephalexin and Ki = 20 WM for nafcillin. These two molecules
were found to reversibly inhibit ampicillin hydrolysis by
9G4H9, but were never found to form any dead-end complex
with the abzyme (data not shown). These latter results
strongly suggest that an intermediary penicilloyl^abzyme in-
termediate is necessary to allow the formation of the irrevers-
ible complex to occur.
All these results lead us to propose a suicide-substrate
mechanism for hydrolysis of ampicillin and penicillin G sub-
strates by 9G4H9. The proposed mechanism states that
9G4H9 can either hydrolyze the substrates or follow a mech-




S. Lefevre et al./FEBS Letters 489 (2001) 25^28 27
The anti-idiotypic approach has allowed us to obtain a
catalyst that could behave as a true L-lactamase for penicil-
linic substrate hydrolysis and as a penicillin-binding protein
(PBP) for forming a stable penicilloyl complex. While L-lac-
tamases and PBPs share primary sequence similarities [17] and
were suggested to be issued from the common ancestral gene
[18] allowing their possible interconversion by mutation
[19,20], the primary sequence of 9G4H9 has no similarity in
primary sequence with both enzymes [21]. The mimicry-based
anti-idiotypic approach could be able to generate three-dimen-
sional structures that resemble that of model enzymes, with
the correct orientation of catalytic residues necessary for cat-
alysis but with a di¡erent linear amino acid sequence and with
some di¡erences in catalytic machinery. The precise character-
ization of the molecular events involved in substrate interac-
tion with 9G4H9, together with the selection of variants of
this antibody will bring new insights both in understanding
the structure^activity relationships between enzymes and ab-
zymes and in understanding the extent of structural and func-
tional mimicry by anti-idiotypic antibodies.
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